Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene

Nat Genet. 1993 Jan;3(1):67-72. doi: 10.1038/ng0193-67.

Abstract

Roughly 25% of human B-cell chronic lymphocytic leukaemias (CLL) are characterized by a chromosomal lesion involving 13q14. This region contains the retinoblastoma gene (RB1). We have used a variety of techniques to determine whether RB1 or some other locus is the critical region in 11 cases of low grade B-cell malignancy (mainly CLL), all with deletions or translocations involving 13q14. In all cases, except the one with minimal disease, there was deletion or a structural lesion in the region of D13S25, with at least 4 cases showing homozygous disruption. We conclude that D13S25 lies close to a tumour suppressor locus whose inactivation contributes to the initiation or progression of low grade B-cell malignancy. This locus is located at least 530 kilobases telomeric to RB1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Blotting, Southern
  • Chromosomes, Human, Pair 13
  • Electrophoresis, Gel, Pulsed-Field
  • Genes, Retinoblastoma*
  • Genes, Tumor Suppressor*
  • Humans
  • Hybrid Cells
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Mice
  • Telomere
  • Tumor Cells, Cultured